- 01910.ON01910. NA ENHANCES CHEMOTHERAPEUTIC AGENT ACTIVITY IN DRUG-RESISTANT CANCERS

摘要

The present invention provides a method of treating cancer, comprising identifying a patient having cancer susceptible to treatment with a nucleotide analogue chemotherapeutic agent; Administering to the subject a mitotic / collagenase (Plk) pathway inhibitor; For the treatment of cancer susceptible to treatment with a nucleotide analogue chemotherapeutic agent, including cancer in which a nucleotide analogous tumor has developed, comprising monitoring the subject for at least one symptom or symptomatic reduction or stabilization of the cancer Compositions and methods.